| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |